Clinical trial
A Randomized Controlled Study for Surgical Treatment of Irreducible Atlantoaxial Dislocation
NCT05847270 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study for Surgical Treatment of Irreducible Atlantoaxial Dislocation
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 11, 2023
- Completion date
- December 31, 2026
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
irreducible atlantoaxial dislocation